Efficacy and Safety of DNN.63.18.040 for the Treatment of Moderate to Severe Pain

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study evaluates the safety and efficacy of DNN.63.18.040 compared with Tramal® for the treatment of moderate to severe pain.
Epistemonikos ID: fab7464dce52f9b89ec2a99f65e4bac75ab5209f
First added on: Oct 20, 2026